Posts Tagged ‘death’

Dosed in juvie jail: Troubled doctors hired to treat kids in state custody

Monday, June 20th, 2011

By Michael LaForgia

Palm Beach Post Staff Writer

By the time Florida started paying Dr. Gold Smith Dorval to counsel and medicate jailed children, the Pembroke Pines psychiatrist already had experience with kids in state custody.

He had used them, authorities said, to bilk the government out of money for the poor.

When Dorval pleaded no contest to a felony grand theft charge, it should have barred him, by law, from working for Florida’s Department of Juvenile Justice.

It didn’t.

And, like Dorval, other doctors have emerged from past troubles and gotten jobs at DJJ – with authority to prescribe drugs to kids in state jails, a Palm Beach Post investigation has found.

Some psychiatrists took DJJ jobs after they were cited for breaking the law, making grave medical missteps or violating state rules. Others were hired after they were accused of overmedicating patients, sometimes fatally.

All were empowered to prescribe drugs to jailed kids as powerful antipsychotic pills flowed freely into Florida’s homes for wayward children.

“It’s appalling. A psychiatrist is a psychiatrist. They’re licensed, they’ve been to medical school, and there is a certain trust placed in that person’s judgment when they tell you that this child needs to be medicated,” said John Walsh, an attorney with the Palm Beach County Legal Aid Society who has represented children in juvenile court. “This just illustrates that we always have to be on guard with children.”

In two years, Florida bought hundreds of thousands of tablets of Seroquel, Abilify, Risperdal and other antipsychotic drugs for children housed in state-run jails and programs. The meds were administered in a juvenile justice system that doesn’t track prescriptions and has no way of telling whether doctors are prescribing to make kids easier to control.

In some jails and homes, pills were prescribed by psychiatrists who took huge speaker fees from companies that make antipsychotic drugs, The Post found. In others, the task fell to doctors with troubled pasts.

In response to the newspaper’s first reports, published last month, DJJ Secretary Wansley Walters launched an investigation into the department’s use of antipsychotic drugs. DJJ officials declined to discuss The Post’s latest findings, citing the probe.

Spokesman C.J. Drake acknowledged, though, that the department has struggled to find psychiatrists willing to work in jails and programs. He also said DJJ sometimes has relied on companies that employ a stable of doctors, rather than signing a contract with a single physician.

As a result, Dorval went to work in a Broward County jail for children – even though he would have failed a state-mandated background check required by the contract.

Doctor’s bogus billings

In the late 1990s, Dorval claimed he was providing juvenile delinquents and other vulnerable children with needed therapy. Instead, state investigators said, he used bogus counselors to bill Medicaid for more than $350,000 in fraudulent claims.

He charged the government for offering more than 24 hours’ worth of children’s therapy in a single day, investigators said, and structured the scheme around kids who were homeless or in DJJ custody or foster care.

He tended to bill “for those children that the system ‘lost,’ ” according to an affidavit for his arrest.

Originally charged with four felonies in Broward, Dorval pleaded no contest to one count of grand theft in 2004.

Later, to keep his medical license, he agreed to pay $10,000 and was suspended, reprimanded and put on four years’ probation.

Although a judge withheld a formal finding of guilt, the plea disqualified Dorval from seeing patients in a juvenile jail. Even so, his employer, Miami-based Compass Health Systems, sent him to work at the Broward Juvenile Detention Center between August and December 2007.

No one screened his background beforehand.

In written responses to questions, Dorval said he was doing as he was told when Compass sent him to work in the Broward juvenile jail.

“At that period you cited, the psychiatrist that was seeing patients at the DJJ was out. Therefore I was designated by the management office to go and cover for that psychiatrist, until they switched me again to another place. I was not aware of any wrongdoing,” wrote Dorval, who stressed that he never signed a contract with DJJ. “I am only an employee. Wherever they send me to work I have to go.”

As for the criminal charges, he offered this explanation: “This case was a simple matter that became complicated, because my first lawyer messed me up.” After wrangling over the facts, “they decided to offer me a plea that would allow me to get a chance to fight for my license to practice medicine,” he wrote. “It was a real nightmare that generated in me a post-traumatic syndrome that I will never forget.”

DJJ officials declined to comment on Dorval’s hiring, again citing the investigation.

Compass officials didn’t respond to questions about Dorval.

DJJ had no contract with Compass as of May, records show.

Patient’s death missed in screening

In state-operated jails and programs, the rules say DJJ must screen doctors’ backgrounds and verify that physicians’ hold valid medical licenses. In privately run programs, which house the majority of children in the department’s custody, that responsibility falls to contracted companies.

Such screenings don’t catch everything: Doctors who kept their licenses after the state accused them of serious lapses have gone on to work in juvenile jails and homes.

Dr. Charles J. Dack is an example. For six years, Dack, a Lakeland-based physician who is board-certified in addiction and child psychiatry, prescribed a cocktail of antidepressants and powerful painkillers, including methadone and morphine, to a patient named Mary Tuxbury.

Eventually, Dack ramped up the doses of pills Tuxbury was taking, keeping her “at a toxic level of morphine for approximately two and a half years,” regulators from the state health department said. In March 2002, Tuxbury was found dead. She was 42.

An autopsy showed she died of “multiple drug intoxication, namely opiates and tricyclic antidepressants.”

Regulators charged Dack with failing to meet care standards and inappropriate prescribing. Dack settled the allegations in August 2007. He admitted no wrongdoing but agreed to pay a $7,000 fine and complete a course on “misprescribing” drugs.

A year later, he was hired to care for children at three privately run programs in Central Florida: Wilson Youth Academy, Peace River Youth Academy and New Beginnings Youth Academy. He worked in the homes until April.

Dack didn’t respond to messages seeking comment.

Doctor hired after child’s death

Other DJJ doctors weren’t cited by regulators, but they were accused in court of fatal neglect. Roughly one in eight of the psychiatrists who have worked for DJJ in the past five years has settled a malpractice lawsuit in Florida, records show.

Among these was Dr. Samuel McClure. As a psychiatrist in Orlando, McClure diagnosed an 11-year-old boy named David Morganthal with attention deficit disorder. He prescribed powerful, mind-altering drugs for David – even though the child was much smaller than other kids his age, according to court documents.

One morning in November 2001, David’s mother woke to find her son dead on the floor of her double-wide mobile home. When they laid David out at the morgue, he measured less than 4-foot-2 and weighed 49 pounds.

Lab tests showed his blood contained an unusually high concentration of an antidepressant: about 60 percent more of the medication than doctors had expected.

The drug, mirtazapine, still hasn’t been approved as safe for children. David was taking the drug along with another antidepressant that hasn’t been approved for kids, citalopram.

The autopsy concluded the boy probably died from a seizure and heart problems caused by “reaction to prescription medication.”

Read the rest of the article here: http://www.palmbeachpost.com/news/state/dosed-in-juvie-jail-troubled-doctors-hired-to-1549240.html?viewAsSinglePage=true

« Return to news items


Share

America’s Most Dangerous Pill? Klonopin.

Thursday, June 2nd, 2011

No "benzo" has been more lethal to millions of Americans than a popular prescription drug called Klonopin

It’s not Adderall or Oxy. It’s Klonopin. And doctors are doling it out like candy, causing a surge of hellish withdrawals, overdoses and deaths.

AlternetJune 1, 2011

by Christopher Byron

You could argue that the deadliest “drug” in the world is the venom from a jellyfish known as the Sea Wasp, whose sting can kill a human being in four minutes—up to 100 humans at a time. Potassium chloride, which is used to trigger cardiac arrest and death in the 38 states of the U.S. that enforce the death penalty is also pretty deadly . But when it comes to prescription drugs that are not only able to kill you but can drag out the final reckoning for years on end, with worsening misery at every step of the way, it is hard to top the benzodiazepines. And no “benzo” has been more lethal to millions of Americans than a popular prescription drug called Klonopin.

Klonopin is the brand name for the pill known as clonazepam, which was originally brought to market in 1975 as a medication for epileptic seizures. Since then, Klonopin, along with the other drugs in this class, has become a prescription of choice for drug abusers from Hollywood to Wall Street. In the process, these Schedule III and IV substances have also earned the dubious distinction of being second only to opioid painkillers like OxyContin as our nation’s most widely abused class of drug.

Photo Credit: Kristin Burns

Seventies-era rock star Stevie Nicks is the poster girl for the perils of Klonopin addiction. In almost every interview, the former lead singer of Fleetwood Mac makes a point of mentioning the toll her abuse of the drug has taken on her life. This month, while promoting her new solo album, In Your Dreams, she told Fox that she blamed Klonopin for the fact that she never had children. “The only thing I’d change [in my life] is walking into the office of that psychiatrist who prescribed me Klonopin. That ruined my life for eight years,” she said. “God knows, maybe I would have met someone, maybe I would have had a baby.”

Nicks checked herself into the Betty Ford Clinic in 1986 to overcome a cocaine addiction. After her release, the psychiatrist in question prescribed a series of benzos—first Valium, then Xanax, and finally Klonopin—supposedly to support her sobriety. “[Klonopin] turned me into a zombie,” she told US Weekly in 2001, according to the website Benzo.org, one of many patient-run sites on the Internet offering information about benzodiazepine addiction, withdrawal and recovery. Nicks has described the drug as a “horrible, dangerous drug,” and said that her eventual 45-day hospital detox and rehab from the drug felt like “somebody opened up a door and pushed me into hell.” Others have described Klonopin’s effects as beginning with an energized sense of euphoria but ending up with horrifying sense of anxiety and paralysis, akin to  sticking your tongue into an electric outlet, or suddenly feeling that your brain is on fire.

When benzodiazepines first came to market in the 1950s and 1960s, they were prescribed for a range of neurological disorders such as epilepsy as well as anxiety related disorders such as insomnia. But over time, a loophole in federal drug-control laws known as the “practice of medicine exception” has permitted psychiatrists and other physicians to prescribe the drugs for any perceived disorder or symptom imaginable, from panic attacks to weight control problems. Much in the same way, Valium became infamous as “mother’s little helper,” a sedative used to pacify a generation of bored and frustrated suburban housewives.

Alcoholics and drug addicts are most likely to run into Klonopin during detox, when it is used to prevent seizures and control the symptoms of acute withdrawal. Klonopin takes longer to metabolize and passes through your system more slowly than other benzos, so in theory you don’t need to take it so frequently. But if you like the high it gives you, and  keep increasing your dosage, the addictive effects of the drug accumulate quickly and can often be devastating. The drug’s label clearly specifies that it is “recommended” only for short-term use—say, seven to 10 days—but once exposed to the pill’s seductive side-effects, many patients come back for more. And not surprisingly, many doctors are happy to refill prescriptions to meet this consumer demand. In the process, countless numbers of people swap one addiction for another, often worse than the initial addiction they were trying to treat. Although benzodiazepines are rarely reported to be the cause of single-drug overdoses, they show up with great frequency in deaths from so-called combined drug intoxication, or CDI. In recent years there have been thousands of deaths caused by this lethal combination. The drug has also help hasten the death of a wide list of otherwise healthy celebrities. :

In 1996, Actress Margaux Hemingway committed suicide by overdosing on a barbiturate-benzodiazepine cocktail. Weeks later, Hollywood movie producer Don Simpson (Beverly Hills Cop) also died from an unintentional benzo-based overdose. Klonopin was one of 11 different prescription drugs—all written by the same doctor—found in the body of Playboy centerfold model Anna Nicole Smith, who OD’d in 2007. Thereafter, the well-known Los Angeles author, David Foster Wallace, who was suffering from a profound depression when a doctor prescribed him Klonopin, went into his backyard on a September evening and hanged himself with a leather belt he had nailed to an overhead beam on his patio. Klonopin has been striking down more than just troubled celebrities, however. In 2008, reports began to surface of soldiers returning from Iraq with post-traumatic stress disorder who were dying in their sleep, the victims of a psych-med cocktail of Klonopin, Paxil (an antidepressant), and Seroquel, an antipsychotic that is routinely prescribed by VA hospitals.

Hospital emergency room visits for benzodiazepine abuse now dwarf those for illegal street drugs by a more than a three-to-one margin. This trend has been increasing for at least the last five years. In 2006, the U.S. government’s Substance Abuse and Mental Health Services Administration published data showing that prescription drugs that year were the number two reason for ER admissions to hospitals for drug abuse, slightly behind illicit substances like heroin and cocaine. But a survey released by the agency earlier this year claims that benzos, opioids and other prescriptions meds are now responsible for the majority of drug-related hospital visits.

Scientists can’t say for sure what Klonopin does when ingested, except that it dramatically affects the functioning of the brain. This much we know: If your brain is on fire with electrical signals—like, say, you’re having an epileptic seizure—a dose of clonazepam will help put out the flames.  It does so by lowering the electrical activity of the brain,  specifically which electrical activities it suppresses is something that no one really seems to know for sure. And therein lies the reason why clonazepam, like nearly the entire class of benzos, causes such unpredictable reactions in people. Put simply, the brain is just too complex a structure for its owners to understand—and when you start monkeying around with the way it functions, it’s anybody’s guess what is going to happen next.

Here’s how the respected neurosurgeon Frank Vertosick, Jr., describes the brain in his book When The Air Hits Your Brain: Parables of Neurosurgery: “The human brain: a trillion nerve cells storing electrical patterns more numerous than the water molecules of the world’s oceans.” So, if clonazepam is given to a patient with a history of epileptic seizures, it is likely to bring the symptoms under control. But give the same drug to a person suffering from a completely different problem (an eating or sleeping disorder, for example), and it might actually cause an epileptic seizure.

Clonazepam has wreaked such havoc on people partly because it is so highly addictive; anyone who takes it for more than a few weeks may well develop a dependence on it. As a result, you can be prescribed Klonopin as a short-term treatment for, say, insomnia, and wind up so hooked on it that you’ll begin frantically “doctor shopping” for new prescriptions if the first physician who gave it for you refuses to renew the prescription. As with all benzos, use of Klonopin for more than a month can lead to a dangerous condition known as “benzodiazepine withdrawal syndrome,” featuring elevation of a user’s heart rate and blood pressure along with insomnia, nightmares, hallucinations, anxiety, panic, weight loss, muscular spasms or cramps, and seizures.

Along with Klonopin, here are the three other benzos that, by general agreement, have made it into the top ranks of the world’s worst and most widely abused drugs: temazepam, alprazolam, and lorazepam.

Temazepam: Sold in the U.S. under the brand name Restoril, this benzo was developed and approved in the 1960s as a short-term treatment for insomnia. It is basically what is commonly called a “knockout drop.” Taken even in relatively modest dosages, temazepam can produce a powerfully hypnotic effect that numbs users and makes them extremely compliant and susceptible to control. But thanks to the “practice of medicine exception” physicians can prescribe it for anything they want.

During the Cold War, the Soviet Union reportedly used temazepam extensively to keep political dissidents in a drugged-out state in government-run psychiatric hospitals. Both the CIA and the KGB are also said to have also used the sleeping pill in prisoner interrogations and in research into mind-control, brainwashing and social engineering.

Temazepam is sometimes referred to as a “date rape” drug, and it figures frequently in drug-related crimes of violence. In the drug world underground, where it is often sold as an alternative to heroin and crack cocaine, it goes by such street names as “tams,” “Vitamin T,” “terminators,” “big T,” “mind eraser” and “Mommy’s Big Helper.” Common side-effects include confusion, clumsiness, chronic drowsiness, impaired learning, memory and motor functions, as well as extreme euphoria, dizziness and amnesia.

Alprazolam: Brand name Xanax, this benzo now accounts for as many as 60% of all hospital admissions for drug addiction, according to some research. What’s more, violent and psychotic responses to Xanax are not limited to humans. In May 2009, a 200-lb chimpanzee being kept as a house pet by a Stamford, Conn., woman went on a rampage after being dosed with Xanax, escaping into the neighborhood and ripping off the face of a friend of its owner.

Lorazepam: Brand name Ativan, this drug has figured in an array of well-publicized homicides and suicides by those using it. Ativan surfaced in the 2000 divorce case between Washington, D.C., socialite Patricia Duff and her husband, Wall Street billionaire Ronald Perelman. In deposition testimony, Perelman acknowledged taking Ativan as an anti-anxiety drug during his separation from Duff and the commencement of divorce proceedings. The period was marked by numerous outbursts by Perelman and at least two physical assaults on Duff. In 2008, news reports revealed that Ativan was being used by the U.S. Customs Service to keep suspected terrorists sedated while deporting them to detention facilities abroad.

You can buy any of these “feel-good” drugs without a doctor’s signature by simply typing the name into any Internet search engine. Instantly, you’ll be presented with dozens of websites, both foreign and domestic, where you can make your purchase, no prescription required. (Most of the websites accept all major credit cards.)

Why has all this happened? In large measure you can thank the 47,000 members of the American psychiatric profession for this dreadful state of affairs. Neither the pharmaceutical industry nor the psychiatric profession would be anywhere near as lucrative as they are today without their mutual support system. Together they have created a marketing juggernaut that over the last 20 years has spawned a seemingly nonstop gusher of profits that is only now beginning to slow—and probably only temporarily.

The scholarly journals of the psychiatric profession were filled with early warnings, beginning almost 50 years ago, from those who could see where the encroaching influence of the drug companies was destined to lead the profession. Now, even the medical journals themselves have been corrupted by the hidden hand of Big Pharma. In 2008, the New York Times reported that a survey of the six top medical journals showed that on average almost 8% of the bylined articles published in their pages were ghostwritten by freelance writers, then published under the names of cooperating doctors and researchers to give the pro-drug messages contained in the articles the appearance of impartiality. The scheme is bankrolled, of course, by the company that makes the drug.

Consider Dr. Joseph Biederman, the world-renowned Harvard University psychiatrist and father of modern psychopharmacology for children, who, it now turns out, has been taking secret “consulting fees” from drug companies for years. Biederman is widely credited with legitimizing the concept of “bipolar disorder” as a chemical imbalance in the brain that can be corrected with psychiatric drugs. But documents uncovered by Senate investigators probing ties between the psychiatric profession and the drug industry, which have resulted in an explosion in medically approved uses for psychiatric drugs for children, show that Biederman received more than $1.6 million in undisclosed payments since 2000 from the pharmaceutical companies manufacturing the drugs he was encouraging parents to give to their children if they appeared to be “bipolar.”

No surveys that I am aware of have ever been conducted regarding the public’s impression of what psychiatrists actually do. But from pop culture media characters such as the fictional female psychiatrist Dr. Jennifer Melfi in the HBO series The Sopranos, the general belief seems to be that psychiatrists are learned and humane professionals who counsel their patients through hour-long “talk therapy” sessions in their offices once a week, and more frequently than that if necessary to help them resolve their conflicts.

In fact, many do nothing of the sort. It may be only a patient’s first session with a psychiatrist that lasts any meaningful amount of time. In this initial consultation the psychiatrist relies on the DSM manual as the diagnostic tool to decide precisely what the patient suffers from. Once that is established, the psychiatrist can begin prescribing psych meds as therapy, free of fear about the danger of a medical malpractice suit lurking down the road.

The follow-up sessions (weekly, monthly, etc.) that come after the initial consultations—that is, the sessions that are portrayed on The Sopranos as the occasions when Mafia killer Tony Soprano sits down in Dr. Melfi’s darkened office and pours out his guts about his troubled childhood—usually last as little as 15 minutes. During these so-called “med checks,” a psychiatrist typically charges $100 or more for asking the patient little more than how he or she is responding to the prescribed medication—a question that can usually be answered by a quick glance at the patient’s demeanor.

At the end of such a med-check, the psychiatrist may decide to renew the patient’s current prescription, substitute or add a new one—or even offer the patient a free sample of some new psych-med, courtesy of a sales rep from a pharmaceutical company. At four med-checks per hour, a psychiatrist with enough patients to fill up his workdays can easily make $120,000 annually from his med-check practice alone and still take a month-long summer vacation.

It’s obvious that this system incentivizes doctors financially to keep prescribing drugs in order to keep patients returning for med-checks. But Big Pharma offers a whole host of additional income opportunities. Last year, ProPublica, the Pulitzer Prize–winning public-interest investigative website, did an extensive report on the financial compensation drug companies shower on physicians. Well-titled “Dollars for Docs,” this series included a database of more than 17,000 doctors who accepted “speaker fees” and other money from eight drug companies in 2009 and 2010 totaling $320 million.

That accounting is only the tip of the iceberg, however, as most pharmaceutical companies have refused to disclose their physician payments. Not surprisingly, most doctors interviewed by ProPublica denied that their medical decisions and prescribing habits were influenced by drug company payments. The new healthcare reform bill calls for greater transparency, requiring all drug-makers to disclose all fees paid to all doctors by 2014. Until then, you can type your doctor’s name into the database to find out if he or she is on the pharma take, and for how much.

http://www.alternet.org/health/151166/america%27s_most_dangerous_pill?page=entire

Christopher Byron is a prize-winning investigative journalist and New York Times best-selling author. His columns and articles have appeared in a dozens of major publications, including New York Magazine, Fortune, The New York Times and The New York Post. He has also been a regular guest commentator on CNN. Fox, and CNBC. This article is exclusively excerpted from his forthcoming book, Mind Drugs, Inc.: How Big Pharma and Modern Psychiatry Have Corrupted Washington and Destroyed Mental Health in America.

« Return to news items


Share

Unregulated prescription of antipsychotic drugs in elder care facilities on the rise

Monday, May 16th, 2011

Santa Cruz Sentinel -  May 15, 2011

A recent study by the Office of the Inspector General of the United States indicates that residents of some nursing homes may be regularly given atypical antipsychotic drugs as a means of chemical restraint, sometimes to the detriment of their health, including death.

The report, published May 9, states: “For the period January 1 through June 30, 2007, we determined using medical record review that 51 percent of Medicare claims for atypical antipsychotic drugs were erroneous.”

A member of Congress requested the office evaluate the extent to which nursing home residents receive atypical antipsychotic drugs and the associated cost to Medicare. The member expressed concern with these drugs were being prescribed for off-label conditions — i.e. conditions other than schizophrenia and/or bipolar disorder — and/or in the presence of a condition specified in the Food and Drug Administration’s boxed warning.

“We determined that 83 percent of Medicare claims for atypical antipsychotic drugs for elderly nursing home residents were associated with off-label conditions and that 88 percent were associated with the condition specified in the FDA boxed warning,” the Office of the Inspector General found.

The California Advocates for Nursing Home Reform has been concerned about this issue for some time. For more information, visit www.canhr.org/help.html

http://www.santacruzsentinel.com/ci_18067580


« Return to news items


Share

Brain Virus Kills Woman After Docs Misdiagnosed Condition as Depression

Wednesday, May 11th, 2011

Fox News
May 10, 2011

Jane Harrop

Jane Harrop

A British woman died from a rare brain virus after being told by doctors that she was simply depressed because she had not had a baby, a coroner’s investigation heard.

Jane Harrop, 30, went to the hospital in February last year with severe head and neck pains after collapsing suddenly but was told she had a migraine, the Birmingham Mail reported Tuesday.

In the months leading up to her collapse, Harrop complained of violent headaches nine times to doctors, who gave her antidepressants and did not refer her for tests, Birmingham Coroner’s Court heard.

“The [doctor] thought she was depressed because she was trying for a baby and hadn’t had one. Jane was a happy-go-lucky character — I didn’t think she was depressed. She said her brain felt like it was being crushed,” according to Harrop’s mother, Linda Cook.

Harrop, who cared for multiple sclerosis patients in their homes, died eight days after she was taken to Good Hope Hospital in Sutton Coldfield, where a brain scan was delayed for five days because she felt claustrophobic and staff had no way of sedating her.

She was not transferred to a specialized brain unit at a nearby hospital because of a lack of beds, the court was told.

Pathologist Dr. Martin Carey said Harrop’s death was caused by inflammation of the brain and spine by a virus that took hold over a period of at least two months. Headaches are the first sign of sub-acute meningo-myeloencephalitis, Carey added.

Another patient on the ward, Jean Paul, said nurses ignored Harrop’s screams of pain during her final night alive.

“She was screaming in pain and shouting for help, but no one came to her,” said Paul. “I was disgusted at the way the poor woman was left.”

The inquest continues.

« Return to news items


Share

Antipsychotic Drugs Called Hazardous for the Elderly

Monday, May 9th, 2011

The New York Times
By Gardiner Harris
May 9, 2011

Nearly one in seven elderly nursing home residents, nearly all of them with dementia, are given powerful atypical antipsychotic drugs even though the medicines increase the risks of death and are not approved for such treatments, a government audit found.

More than half of the antipsychotics paid for by the federal Medicare program in the first half of 2007 were “erroneous,” the audit found, costing the program $116 million for those six months.

“Government, taxpayers, nursing home residents as well as their families and caregivers should be outraged and seek solutions,” Daniel R. Levinson, inspector general of the Department of Health and Human Services, wrote in announcing the audit results.

Mr. Levinson noted that such drugs — which include Risperdal, Zyprexa, Seroquel, Abilify and Geodon — are “potentially lethal” to many of the patients getting them and that some drug manufacturers illegally marketed their medicines for these uses “putting profits before safety.”

The audit is an unusual assessment by the government of whether doctors are treating Medicare patients appropriately in nursing homes. Mr. Levinson suggested that the government should collect information on the diagnoses given Medicare patients so that the government can assess whether the drugs prescribed to them are appropriate.

While common in the private sector, such basic oversight is unheard of in the Medicare program and would almost certainly be opposed by doctors’ groups and many in Congress who view government intrusions into the doctor-patient relationship as inappropriate. In response to the audit, the Centers for Medicare and Medicaid Services said that some of the inappropriate use of antipsychotics in elderly nursing home patients is a result of drug makers’ paying kickbacks to nursing homes to increase prescriptions for the medicines.

Omnicare Inc., a pharmacy chain for nursing homes, paid $98 million in November 2009 to settle accusations that it received kickbacks from Johnson & Johnson and other drug makers for antipsychotic prescriptions.

Medicare officials said that diagnosis information is not generally included with prescriptions so the government cannot assess in real time whether prescription payments are appropriate.

While the Food and Drug Administration has warned doctors that using antipsychotic drugs in elderly patients with dementia increases their risks of death, doctors continue the practice because they have few other good choices, said Dr. Daniel J. Carlat, editor in chief of The Carlat Psychiatry Report, a medical education newsletter for psychiatrists.

“Doctors want to maximize quality of life by treating the patient’s agitation even if that means the patient will die a bit sooner,” Dr. Carlat said.

The government auditors found that of the 2.1 million elderly patients in nursing homes during the first six months of 2007, 304,983 had at least one Medicare claim for an antipsychotic medicine. Nursing home residents received 20 percent of the 8.5 million claims for antipsychotic medicines for all Medicare beneficiaries at a cost of $309 million during those six months.

The auditors found that 83 percent of antipsychotic prescriptions for elderly nursing home residents were for uses not approved by federal drug regulators, and 88 percent were to treat patients with dementia — for whom the drugs can be lethal.

“These results are alarming,” said Senator Charles E. Grassley, Republican of Iowa, who asked for the audit. “Medicare officials need to pay attention.”

Federal rules require that any drugs that are paid for by the government be given only for uses that are approved either by the government or one of three independent drug usage encyclopedias. Auditors found that 51 percent, or 726,000 of 1.4 million claims, for antipsychotic medicines did not meet this criterion and were thus paid for by the government improperly.

Government rules also ban drugs that are used in excessive doses or duration, even if patients are found to have a condition for which the drug is appropriate. Auditors found that 22 percent, or 317,971 of 1.4 million claims, for antipsychotic medicines failed this standard.

Read article here:  http://www.nytimes.com/2011/05/10/health/policy/10drug.html?_r=2

« Return to news items


Share

Will we ever wake up to the deadly risks of happy pills?

Tuesday, December 14th, 2010
The Daily Mail, December 13, 2010
by John Nash

As new research reveals antidepressants raise the danger of heart attacks, the disturbing cost of this modern addiction

Just as David Cameron launches his campaign to boost national happiness, along comes grim news for the 12 million Britons taking happy pills. London-based researchers have just announced that antidepressants raise the risk of fatal heart attacks.

This research is only the latest wake-up call for a nation hooked on happy pills. Might we finally heed the warnings and shake ­ourselves out of our pharmaceutical stupor?

It is high time we did: a small mountain of studies shows that antidepressant drugs are largely ineffective. But more than that, they can ruin lives by creating chronic dependency and a grinding ­hopelessness that ­sometimes leads to self-neglect and death.

The latest study, by Dr Mark Hamer, a ­public health researcher at University ­College ­London, shows that people on the older drugs — tricyclic antidepressants — are at far higher risk of cardiovascular disease than those ­taking the newer class of pills, selective ­serotonin reuptake inhibitors (SSRIs).

But if I were taking SSRIs, I would not be cheered by the findings. Tricyclics were ­discovered in the Forties and it is only now we have identified these dangerous effects.

Moreover, some SSRI drugs are known to cause serious problems such as stomach bleeding. In addition, the withdrawal ­symptoms can be so severe that patients may become dependent on them.

Dr Hamer says his findings do not only affect people with depression, because antidepressants are also prescribed to people with back pain, headache, anxiety and sleeping problems.

Last year, according to Dr ­Hamer’s ­figures, about 33 million antidepressant prescriptions were dispensed in England.

At some point, surely, there will be no one left to prescribe for. In my view, it’s fast becoming one of the greatest medical scandals of our age.

The most worrying thing about these drugs is not their side-effects, but their widespread non-effect: they just don’t work for most ­people with mild to moderate depression.

Two years ago, researchers at Hull ­University concluded that the pills only benefit ­people who are most seriously, clinically depressed. In these extreme cases, there is often a physical problem in their brain, a result of genetics or accident. But what of the rest?

There is a growing view that many people are being needlessly drugged because the natural state of feeling unhappy is viewed as an illness, rather than a ­normal part of life that we should experience and learn from.

An American study of 8,000 ­people who had been treated for depression found that a quarter of them were not clinically sick, but had just undergone a normal life event such as bereavement.

Their symptoms, it said, should be left to pass naturally (that, of course, would be a blow to the drug manufacturers, who profit so handsomely from the mass ­consumption of their mind-numbing chemicals).  For most of us, the healthiest option is to face our problems, rather than disappear down a black hole of antidepressant dependency.

One leading expert, Randolph Nesse, a psychiatry professor at Michigan University, argues that this mild form of depression is ­beneficial, often ­interjecting in life to tell us to stop what we are doing and reconsider.

This can help, he says, when something awful happens to us, such as a job loss or relationship break-up, when it makes sense to slow down to grieve, reassess and make changes.

But instead, we live in a world that tells us that when we feel out of sorts we need a pill to recover.

It is this belief that ­creates queues of patients at the doors of hard-pressed GPs, who often feel they have no option but to hand out happy pills as though they were sweeties.

Many patients later claim they couldn’t have coped without them. They will swear that ‘the drugs make me feel better, so they must be working’. But often the drugs do not actually work as chemicals. Instead, they merely reassure us — the so-called placebo effect.

In 2008, Professor Irving Kirsch at Hull University found something strange when he took a close look at some figures from drug manufacturers’ own trials of four common antidepressants.

The drugs improved patients’ sense of wellbeing. So far, so ­unremarkable.

But many of those involved in the trials were given sugar pills instead of antidepressants.

And their depression scores improved just as much as those on the real pharmaceuticals. In other words, the placebo patients put so much store by the magical (and much-promoted) power of antidepressants that they lifted their own morale without any genuine chemical intervention. Such is the life-enhancing power of human belief.

Everybody hurts: Sadness is a part of life and shouldn’t always be treated as an illness

But this phenomenon also has a dark side: the opposite of placebo, which is called the ‘nocebo’ effect.

This occurs when you convince someone that a particular thing will do them harm, and they begin to feel sick.

Talk to someone about food poisoning while they are tucking into a hearty meal and you will see the nocebo effect at work.

Sadness is a part of life and shouldn't always be treated as an illness

Something similar is happening in our pill-obsessed world. When we are convinced that we need drugs to get us out of an ­emotional crisis, we stop doing things to help ourselves.

This was clear from the latest research. Dr Hamer found that tricyclic drugs raise a person’s heart attack risk.

But that risk was dwarfed by another danger: the people ­taking the drugs often lost the will to look after themselves properly. They were more likely to smoke, be overweight and not exercise.

Dr Hamer says that if they started living more healthily they would cut their heart attack risk by three times. Exercise and weight loss would also help alleviate their depression and anxiety.

But people stuck in the role of helpless drug-munchers often ­cannot make that change for themselves.

They simply sit waiting for their questionable pills to work. And when the pills fail, they become even more demoralised. It’s a vicious cycle, and one that’s ­sucking in more and more vulnerable people.

Read more: http://www.dailymail.co.uk/health/article-1338340/Will-wake-deadly-risks-happy-pills.html#ixzz186xwdATE

« Return to news items


Share

Girl, 2, had twice the amount of anti-psychotic drug in her system as adult dosage

Friday, December 10th, 2010

Note from CCHR:  Though this toddlers death is being investigated as an accidental ingestion of the drug, as hard as it is to  comprehend, this is fact—the prescribing of psychiatry’s most powerful drugs,  antipsychotics,  to infants and toddlers has become commonplace. These drugs are so strong they can cause brain atrophy (shrinkage), tardive dyskinesia (involuntary muscle spasms that can be permanent), diabetes, cardiac events,  and death.   CCHR’s Drug Database contains the adverse reactions to psychiatric drugs that have been filed with the US FDA by doctors, pharmacists, health care providers and others over a 4 year period.  For just this one antipsychotic drug alone (Haldol), the database contains 45 reports of adverse reactions for children 3 years old and under, 41 of which were reported to the FDA by medical doctors.  One antipsychotic.  There are many others.  Keep in mind that by the FDA’s  own admission, only 1-10% of side effects are ever reported to them.    See the reports here: http://www.cchrint.org/psychdrugdangers/medwatch_psych_drug_adverse_reactions.php

Grand Rapids Press – December 10. 2010

by John Tunisun

Awtumn Minnema, 2, and her father, Nathan Minnema

WALKER — Awtumn Minnema, the 2-year-old who died Nov 15 from a prescription drug overdose, had twice the amount of an anti-psychotic drug in her system as a single adult dose, a pathologist said today.

Dr. Stephen Cohle, who performed the autopsy on Awtumn, said toxicology reports showed the girl died from too much haloperidol, sold as Haldol, in her system.

Haldol is anti-psychotic drug most often used to treat schizophrenia.

Awtumn was with her mother at a relative’s birthday party on Three Mile Road NW when she apparently ingested the drug.

Her father, Nathan Minnema, was not at the party but was told later that family members tried to make the girl vomit on the belief she had swallowed pills that fell from a broken shelf to the floor. She did not vomit, however, and was put in bed.

She was discovered early the next afternoon in her crib, not breathing.

Walker police say the investigation is open and say they do not know whether anyone will face criminal charges.

Cohle, a forensic pathologist at Spectrum Health Blodgett hospital, said Haldol is generally safe for adults. But it could cause the heart to slow or stop and impaired breathing in a child, he said.

http://www.mlive.com/news/grand-rapids/index.ssf/2010/12/girl_2_had_twice_the_amount_of.html


« Return to news items


Share

Another Psychiatric Drug, Another Potential Criminal Investigation—J&J’s Antipsychotic Risperdal

Thursday, November 11th, 2010

Wall Street Journal, November 10, 2010

by Peter Loftus of Dow Jones Newswires

Johnson & Johnson (JNJ) said it’s in discussions with the government to resolve a long-running investigation of whether it improperly marketed the antipsychotic Risperdal.

“Discussions are ongoing in an effort to resolve potential criminal and civil litigation arising from these matters,” J&J disclosed in a regulatory filing Wednesday. “Whether a resolution can be reached and on what terms is uncertain.”

J&J spokesman Jeff Leebaw declined further comment.

Risperdal, which is approved to treat schizophrenia and bipolar disorder, was once J&J’s best-selling drug, with global sales of about $4.9 billion in 2007, according to IMS Health, before its oral formulation lost patent protection and cleared the way for generic competition.

J&J has previously disclosed government inquiries regarding Risperdal and later, a newer antipsychotic, Invega, but hadn’t previously said it was in talks for a settlement.

In 2004, the Office of the Inspector General of the U.S. Office of Personnel Management issued a subpoena seeking documents regarding sales and marketing of Risperdal, as well as payments to physicians and clinical trials for the drug, from 1997 to 2002.

The U.S. Attorney’s Office in Philadelphia sent an additional subpoena in 2005, seeking information about Risperdal marketing and adverse reactions associated with the drug. Grand jury subpoenas have been issued seeking testimony from various witnesses.

Earlier this year, J&J, of New Brunswick, N.J., disclosed the government had served civil investigative demands seeking additional information about the marketing of Risperdal and Invega.

Other makers of popular antipsychotics have settled government probes of marketing practices in recent years. In April, AstraZeneca PLC (AZN) agreed to pay about $520 million to resolve Justice Department allegations that it promoted Seroquel off label, or for uses not approved by the Food and Drug Administration.

Last year, Eli Lilly & Co. (LLY) agreed to pay more than $1.4 billion and pleaded guilty to a criminal charge, admitting it promoted the antipsychotic Zyprexa for off-label uses including treatment of dementia in the elderly.

The drugs also have been linked to safety risks, including increased risk of death if used by elderly patients with dementia-related psychosis, as well as weight gain.

Several U.S. states have filed lawsuits against J&J seeking reimbursement of Medicaid funds used to pay for off-label uses of Risperdal, as well as compensation for treating beneficiaries for alleged adverse reactions to the drug.

In October, a jury in Louisiana awarded the state $257.7 million after concluding that J&J minimized the drug’s risk of causing weight gain leading to diabetes. J&J said it would appeal the verdict because the jury wasn’t properly told of applicable legal standards, and certain evidence was excluded. J&J said it didn’t violate the law.

Read the rest of the article here: http://online.wsj.com/article/BT-CO-20101110-717532.html

« Return to news items


Share

Psychiatric Hospital staff ‘puzzled’ by teenager’s fatal overdose—maybe they should brush up on their drug warnings

Tuesday, November 2nd, 2010

Note from CCHR:  This is pure negligence.  A teenager who was under psychiatric “care” was  found dead with two antipsychotic drugs in his system.  The consulting psychiatrist says he is “puzzled” about his death and that they have “no explanation at all.”  Really.   Perhaps the good doctor should brush up on the international drug regulatory warnings for the drugs they are prescribing.    CCHR’s psychiatric drug database contains 24 international drug regulatory warnings on Antipsychotic drugs, and 49 international studies citing side effects including diabetes, obesity, blood clots, heart problems,  cardiac events,  cancer, tumors, death/sudden death. Moreover, if as the psychiatrist claims,  this teenager was found to have two antipsychotics in his system, only one of which was prescribed (so they say) then obviously the psychiatric hospital staff is beyond negligent if in fact a teen already under the influence of mind-altering drugs, was able to get his hands on and ingest another psychiatric drug unbeknown to any of the staff.

A teenager with schizophrenia was found dead in a psychiatric hospital with a cocktail of drugs in his bloodstream, an inquest heard.

Patrick Bennett was discovered in his bed by a shocked nurse at Fulbourn Hospital, and a post-mortem revealed he had taken two anti-psychotic drugs – only one of which he had been prescribed – and paracetamol.

But doctors told an inquest in Huntindon they had no idea how the 19-year-old obtained them, and that he was too mentally ill to have planned and carried out a suicide.

Sue Lancaster, a staff nurse at the hospital, spoke of the moment she found the body of Mr Bennett, of Pound Lane, Kimbolton, on the morning of August 12, 2009.

She said: “It was then I saw his face and knew he was dead. His face still haunts me.”

Fellow nurse Margaret Molina said she was “certain” she had given Mr Bennett the correct dosage of 4.5ml of clozapine, an anti-psychotic drug, on the night before his death.

When asked about his behaviour, she added: “He didn’t seem clearly anxious or upset in any way, he just seemed bewildered.”

Dr Emilio Fernandez, a consultant psychiatrist who had assessed Mr Bennett, said he had “severe impairment in many daily activities”.

He told the inquest doctors suspected Mr Bennett had been hiding tablets in his mouth, so he was switched to a liquid form of clozapine.

He said this switch made his behaviour “more warm”, and he was transferred to a different ward days before his death.

Dr Fernandez described Mr Bennett as “one of the most severe cases I have ever seen in my life” who would not have had the “ability to plan or carry out any suicide attempt”.

He added: “We are all very puzzled about this, we have no explanation at all.”

Search international warnings and studies on antipsychotic and other psychiatric drugs here: http://www.cchrint.org/psychdrugdangers/drug_warnings.php

Search for deaths reported to the US FDA from antipsychotic drugs here http://www.cchrint.org/psychdrugdangers/medwatch_psych_drug_adverse_reactions.php

Read the rest of the article here:  http://www.cambridge-news.co.uk/Home/Hospital-staff-puzzled-by-teenagers-fatal-overdose.htm

« Return to news items


Share

Anxiety and Insomnia Drugs Elevate Risk of Death

Saturday, October 9th, 2010

Note from CCHR: For more on anti-anxiety drugs ( Benzodiazepines commonly known as Xanax, Klonopin, Ativan etc ) including side effects reported to the U.S. FDA, visit our decoded Medwatch reports here: http://www.cchrint.org/psychdrugdangers/medwatch_psych_drug_adverse_reactions.php

(NaturalNews)

If you’ve the habit of popping sleeping pills or tranquilizers like candy, this study could be a life-saving wake-up call for you: Taking sleeping and anxiety-relieving medications significantly elevate your risk of death!

Researchers at Universite Laval, Canada, found that using prescription drugs to treat insomnia and anxiety increases one’s mortality risk by 36 percent, even after controlling for lifestyle behaviors that affect mortality rate, such as alcohol use, smoking, health condition and the level of physical activity.

The conclusion reached by Professor Genevieve Belleville and his team was based on 12 years of records of some 14,000 Canadians from Statistics Canada’s National Population Health Survey. According to the team, the data comes from surveys which were carried out every two years between 1994 and 2007. It contains information on the social demographics, lifestyle and health of participants between the ages of 18 to 102.

The researchers proposed that the side effects caused by sleeping and anti-anxiety medications could be the reasons behind the link. Sleeping pills and anti-anxiety drugs are known to slow reaction time, cause drowsiness, impair thinking and wreck havoc on coordination. These effects would significantly increase one’s chances of meeting with an accident, especially among the elderly.

Statement about the study added that: “They [Sleeping and anti-anxiety medications] may also have an inhibiting effect on the respiratory system, which could aggravate certain breathing problems during sleep. These medications are also central nervous system inhibitors that may affect judgment and thus increase the risk of suicide.”

What isn’t mentioned is that there are also genuine safety concerns related to the use of tranquilizers and sleeping pills. Use them together or mix any of them with alcohol or FDA-approved painkillers can produce serious drug interaction and even cause death. In 2008, a casual combination of anti-anxiety and sleeping drugs ended Australian actor Heath Ledger’s life abruptly. Initially thought to be a case of recreational drug abuse, an autopsy instead found Xanax, Valium, Restoril and other pharmaceuticals commonly used for treating insomnia, anxiety, depression and pain inside Ledger’s body.

Recognizing the real dangers involving sleeping and anti-anxiety drugs, Dr. Belleville warned: “These medications aren’t candy, and taking them is far from harmless. Given that cognitive behavioral therapies have shown good results in treating insomnia and anxiety, doctors should systematically discuss such therapies with their patients as an option.”

Details of the study can be found in the Canadian Journal of Psychiatry.

Sources:

Use of medication for insomnia or anxiety increases mortality risk by 36 percent (http://www.eurekalert.org/pub_relea…)

Benzodiazepine Use and the Risk of Motor Vehicle Crash in the Elderly (http://jama.ama-assn.org/cgi/conten…)

Benzodiazepine Side Effects (http://en.wikipedia.org/wiki/Benzod…)

Heath Ledger Cause of Death Confirmed: Prescription Drug Toxicity (http://www.naturalnews.com/022602.html)

Visit NaturalNews.com here http://www.naturalnews.com/029949_insomnia_drugs_death.html

« Return to news items


Share